Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Current Drug Targets

• Publication date

  2015-06-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/1389450116666150126105002PMID 25619752
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

  2014cited by this paper
• The risk of heart failure associated with the use of noninsulin blood glucose-lowering drugs: systematic review and meta-analysis of published observational studies

  2014cited by this paper
• Gliptins – do they increase cardiovascular risk or benefit?

  2014cited by this paper
• Downregulation of Sirt1 as aging change in advanced heart failure

  2014cited by this paper
• Seven sirtuins for seven deadly diseases of aging.

  2013cited by this paper
• Doxorubicin induces senescence and impairs function of human cardiac progenitor cells

  2013cited by this paper
• Resveratrol‐mediated apoptosis of hodgkin lymphoma cells involves SIRT1 inhibition and FOXO3a hyperacetylation

  2013cited by this paper
• Cancer-drug discovery and cardiovascular surveillance.

  2013cited by this paper
• Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence

  2013cited by this paper
• Small-molecule allosteric activators of sirtuins.

  2013cited by this paper
• The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine

  2013cited by this paper
• Cancer drugs and the heart: importance and management.

  2013cited by this paper
• Emerging beneficial roles of sirtuins in heart failure

  2012cited by this paper
• Administration of Cardiac Stem Cells in Patients With Ischemic Cardiomyopathy: The SCIPIO Trial Surgical Aspects and Interim Analysis of Myocardial Function and Viability by Magnetic Resonance

  2012cited by this paper
• Cardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart

  2012cited by this paper
• Inhibition of AMP-activated Protein Kinase α (AMPKα) by Doxorubicin Accentuates Genotoxic Stress and Cell Death in Mouse Embryonic Fibroblasts and Cardiomyocytes

  2012cited by this paper
• Critical Reevaluation of Endothelial Progenitor Cell Phenotypes for Therapeutic and Diagnostic Use

  2012cited by this paper
• Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial.

  2012cited by this paper
• Resveratrol Treatment Reduces Cardiac Progenitor Cell Dysfunction and Prevents Morpho-Functional Ventricular Remodeling in Type-1 Diabetic Rats

  2012cited by this paper
• Pressure overload leads to an increase of cardiac resident stem cells

  2012cited by this paper
• Cardiac cell therapy: where we've been, where we are, and where we should be headed.

  2011cited by this paper
• SCIPIO brings new momentum to cardiac cell therapy.

  2011cited by this paper
• Cardiovascular disease: cause of morbidity and mortality in adult survivors of childhood cancers.

  2011cited by this paper
• Insulin-Like Growth Factor-1 Receptor Identifies a Pool of Human Cardiac Stem Cells With Superior Therapeutic Potential for Myocardial Regeneration

  2011cited by this paper
• Growth Factor-Induced Mobilization of Cardiac Progenitor Cells Reduces the Risk of Arrhythmias, in a Rat Model of Chronic Myocardial Infarction

  2011cited by this paper
• Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy

  2011cited by this paper
• Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology

  2011cited by this paper
• Resident cardiac stem cells.

  2011cited by this paper
• Emerging roles of SIRT1 deacetylase in regulating cardiomyocyte survival and hypertrophy.

  2011cited by this paper
• Effects of age and heart failure on human cardiac stem cell function.

  2011cited by this paper
• Insights into the mechanism of enhanced mobilization of hematopoietic progenitor cells and release of CXCL12 by a combination of AMD3100 and aminoglycoside–polyarginine conjugates

  2011cited by this paper
• Human cardiac and bone marrow stromal cells exhibit distinctive properties related to their origin.

  2011cited by this paper
• Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation

  2011cited by this paper
• Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.

  2011cited by this paper
• Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine models

  2011cited by this paper
• SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2

  2010cited by this paper
• Anthracycline Cardiomyopathy Is Mediated by Depletion of the Cardiac Stem Cell Pool and Is Rescued by Restoration of Progenitor Cell Function

  2010cited by this paper
• Mammalian sirtuins: biological insights and disease relevance.

  2010cited by this paper
• Juvenile Exposure to Anthracyclines Impairs Cardiac Progenitor Cell Function and Vascularization Resulting in Greater Susceptibility to Stress-Induced Myocardial Injury in Adult Mice

  2010cited by this paper
• Myocardial remodeling after infarction: the role of myofibroblasts

  2010cited by this paper
• Induction of Manganese Superoxide Dismutase by Nuclear Translocation and Activation of SIRT1 Promotes Cell Survival in Chronic Heart Failure*

  2010cited by this paper
• Long-Term Survivors of Childhood Cancers in the United States

  2009cited by this paper
• Hypoxic Preconditioning Enhances the Benefit of Cardiac Progenitor Cell Therapy for Treatment of Myocardial Infarction by Inducing CXCR4 Expression

  2009cited by this paper
• Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway.

  2009cited by this paper
• Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity

  2009cited by this paper
• HSP27 regulates p53 transcriptional activity in doxorubicin-treated fibroblasts and cardiac H9c2 cells: p21 upregulation and G2/M phase cell cycle arrest.

  2008cited by this paper
• Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium.

  2008cited by this paper
• Anthracycline cardiotoxicity: from bench to bedside.

  2008cited by this paper
• Activation of Cardiac Progenitor Cells Reverses the Failing Heart Senescent Phenotype and Prolongs Lifespan

  2008cited by this paper
• Formation of large coronary arteries by cardiac progenitor cells

  2008cited by this paper
• Drug-review deadlines and safety problems.

  2008cited by this paper
• Cardiotoxicity of antitumor drugs.

  2008cited by this paper
• DOXO-EMCH (INNO-206): the first albumin-binding prodrug of doxorubicin to enter clinical trials

  2007cited by this paper
• Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management.

  2007cited by this paper
• Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition

  2007cited by this paper
• Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis.

  2007cited by this paper
• Human cardiac stem cells

  2007cited by this paper
• Sirt1 Regulates Aging and Resistance to Oxidative Stress in the Heart

  2007cited by this paper
• Preconditioning and postconditioning: united at reperfusion.

  2007cited by this paper
• Mitochondrial and Nuclear p53 Localization in Cardiomyocytes: Redox Modulation by Doxorubicin (Adriamycin)?

  2007cited by this paper
• SDF‐1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction

  2007cited by this paper
• Cellular senescence: when bad things happen to good cells

  2007cited by this paper
• Cardiac safety and antitumoral activity of a new nitric oxide derivative of pegylated epirubicin in mice

  2007cited by this paper
• Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium.

  2007cited by this paper
• Diabetes Promotes Cardiac Stem Cell Aging and Heart Failure, Which Are Prevented by Deletion of the p66shc Gene

  2006cited by this paper
• Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in vitro and rat cardiac ventricles in vivo.

  2006cited by this paper
• A Side Order of Stem Cells: The SP Phenotype

  2006cited by this paper
• Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.

  2005cited by this paper
• Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function.

  2005cited by this paper
• Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction.

  2005cited by this paper
• Why drugs fail--a study on side effects in new chemical entities.

  2005cited by this paper
• Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure.

  2005cited by this paper
• Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment.

  2005cited by this paper
• Cardiac stem cells and mechanisms of myocardial regeneration.

  2005cited by this paper
• Cardiac Stem Cells Possess Growth Factor-Receptor Systems That After Activation Regenerate the Infarcted Myocardium, Improving Ventricular Function and Long-Term Survival

  2005cited by this paper
• Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells ‘hide out’ in the bone marrow

  2004cited by this paper
• Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer.

  2004cited by this paper
• Doxorubicin treatment in vivo activates caspase‐12 mediated cardiac apoptosis in both male and female rats

  2004cited by this paper
• Tissue-specific muscle, neural and liver stem/progenitor cells reside in the bone marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood during stress and tissue injury.

  2004cited by this paper
• Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity

  2004cited by this paper
• The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia.

  2004cited by this paper
• Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium

  2004cited by this paper
• Differential regulation of apoptotic cell death in senescent human cells.

  2004cited by this paper
• Senescence and Death of Primitive Cells and Myocytes Lead to Premature Cardiac Aging and Heart Failure

  2003cited by this paper
• Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.

  2003cited by this paper
• Autologous bone-marrow stem-cell transplantation for myocardial regeneration.

  2003cited by this paper
• Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation.

  2003cited by this paper
• Prometheus's vulture and the stem-cell promise.

  2003cited by this paper
• Reversal of human cellular senescence: roles of the p53 and p16 pathways

  2003cited by this paper
• Adult cardiac stem cells are multipotent and support myocardial regeneration.

  2003cited by this paper
• The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert panel review

  2003cited by this paper
• Expression of Functional CXCR4 by Muscle Satellite Cells and Secretion of SDF‐1 by Muscle‐Derived Fibroblasts is Associated with the Presence of Both Muscle Progenitors in Bone Marrow and Hematopoietic Stem/Progenitor Cells in Muscles

  2003cited by this paper
• Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy

  2003cited by this paper
• Damaged epithelia regenerated by bone marrow–derived cells in the human gastrointestinal tract

  2002cited by this paper
• Hematopoietic competence is a rare property of neural stem cells that may depend on genetic and epigenetic alterations

  2002cited by this paper
• Chimerism of the transplanted heart.

  2002cited by this paper
• Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans

  2002cited by this paper
• Mobilized bone marrow cells repair the infarcted heart, improving function and survival

  2001cited by this paper
• Evidence that human cardiac myocytes divide after myocardial infarction.

  2001cited by this paper
• hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.

  2001cited by this paper

• The role of doxorubicin in the formation of cardiotoxicity is a consensus statement. Part II. Cardiotoxicity of doxorubicin unrelated to myocytes and cardioprotection strategy (review)

  2024cites this paper
• Cardiomyopathies and Arrhythmias Induced by Cancer Therapies

  2020cites this paper
• Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia

  2020cites this paper
• Chapter 2 Doxorubicin Cardiotoxicity : Multiple Targets and Translational Perspectives

  2019cites this paper
• Doxorubicin Cardiotoxicity: Multiple Targets and Translational Perspectives

  2018cites this paper
• Doxorubicin targets multiple players: A new view of an old problem

  2018cites this paper
• Updates in Anthracycline-Mediated Cardiotoxicity

  2018cites this paper
• Doxorubicin cardiotoxicity and target cells: a broader perspective

  2016cites this paper
• Heme oxygenase in cardiac repair and regeneration.

  2016cites this paper